| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Gershell Leland serves as a Chief Financial Officer at CAPR. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $8K at current prices.
The biggest single holding is CAPR (~$8K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 2,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2016 | CAPR Capricor Therapeutics, Inc. | Chief Financial Officer | Buy | 2,100 | $2.40 | $5,040.00 | New |